Galderma announces release of topical acne treatment gel
FORT WORTH, Texas Galderma Labs has announced the availability of a topical gel for treating acne.
The Food and Drug Administration approved Epiduox2122 Gel (adapalene and benzoyl peroxide) in December. Galderma calls it the first and only once-daily topical acne treatment that combines adapalene and benzoyl peroxide and expects it to reach pharmacy shelves during the first three months of this year.
“Both adapalene and benzoyl peroxide have extensive histories of efficacy in treating acne, and the data demonstrates that Epiduox2122 Gel has an even more powerful treatment effect than either monotherapy without compromising tolerability,” Henry Ford Hospital director of clinical research and division head of dermatology Linda Gold said in a statement.
Researchers test administering medication using nanotechnology, gold
NEW YORK Researchers have developed a way to use tiny particles of gold to control the administration of drugs for diseases such as cancer, according to a study published in the journal ACS Nano.
The researchers, at the Massachusetts Institute of Technology, created a device that shines infrared light on particles of gold coated with medicine.
The particles vary in size, causing them to melt at different rates depending on the intensity of the light.
The researchers said the device would allow medicine to target specific areas of the body at specific rates, thus minimizing damage to healthy tissue.
N.J. tests new law requiring vaccinations for school-age children
TRENTON, N.J. New Jersey will find out this week if its new law requiring flu vaccinations for schoolchildren has worked, according to published reports.
The state is the first in the country to require schoolchildren to receive flu vaccinations, between the ages of 6 months and 5 years. It required the children to receive the vaccinations by Dec. 31. Children who have not been vaccinated will not be allowed to attend school.